Atypical antipsychotics normalize low-gamma evoked oscillations in patients with schizophrenia

Psychiatry Res. 2017 Jan:247:214-221. doi: 10.1016/j.psychres.2016.11.030. Epub 2016 Nov 26.

Abstract

The symptoms of schizophrenia might be mediated by a cortical network disconnection which may disrupt the cortical oscillatory activity. Steady-state responses are an easy and consistent way to explore cortical oscillatory activity. A chirp-modulated tone (increasing the frequency of the modulation in a linear manner) allows a fast measure of the steady-state response to different modulation rates. With this approach, we studied the auditory steady-state responses in two groups of patients with schizophrenia (drug-naive and treated with atypical antipsychotic drugs), in order to assess the differences in their responses with respect to healthy subjects, and study any potential effect of medication. Drug-naive patients had reduced amplitude and inter-trial phase coherence of the response in the 30-50Hz range, and reduced amplitude of the response in the 90-100Hz range, when compared to controls. In the treated patients group, the response in the 30-50Hz range was normalized to values similar to the control group, but the reduction in amplitude in the 90-100Hz range remained as in the drug-naive group. These results suggest that gamma activity impairment in schizophrenia is a complex phenomenon that affects a wide band of frequencies and may be influenced by antipsychotic treatment.

Keywords: Antipsychotic treatment; Oscillatory activity; Schizophrenia; Steady-state responses.

MeSH terms

  • Acoustic Stimulation / methods
  • Adult
  • Antipsychotic Agents / pharmacology*
  • Electroencephalography / methods
  • Evoked Potentials, Auditory / drug effects*
  • Female
  • Gamma Rhythm / drug effects*
  • Humans
  • Male
  • Middle Aged
  • Schizophrenia / drug therapy
  • Schizophrenia / physiopathology*
  • Schizophrenic Psychology*

Substances

  • Antipsychotic Agents